Iaso™ Siberian Chaga is the latest challenger of 100% pure TOXIN-FREE adaptogens.  An extremely qualified competitor, first approved in 1955 by Moscow’s Medical Academy of Science as a cancer drug.  It was later administered to athletes, astronauts and other Soviet elite to take on a daily basis to improve physical and mental work capacity.

Siberian Chaga is documented for successfully treating cancers of the stomach, lungs, breasts and cervix. Two studies in 1996 found it to have an inhibitory effect on both influenza and HIV. It stimulates the body’s natural immune functions (something that was first confirmed in 2002 and then again in 2005); which may also help explain the historical use of Siberian Chaga extract as an anti-inflammatory.